Skip to content

Misoprostol for preventing postpartum haemorrhage

Optimising the dose of Misoprostol for the prevention of postpartum haemorrhage: a randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN97277056
Enrollment
60
Registered
2010-05-13
Start date
2009-08-16
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum haemorrhage Pregnancy and Childbirth Postpartum haemorrhage

Interventions

Treatment groups: 200 mcg or 400 mcg or 600 mcg sublingual misoprostol given once immediately post partum. Control group: 10 IU IM oxytocin. Observation of intrauterine pressure and vital sign for 1

Sponsors

University of Liverpool (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women who have had spontaneous vaginal delivery 2. Women with gestational age >34 weeks 3. Women who give an informed written consent 4. Aged = 18 years

Exclusion criteria

Exclusion criteria: 1. Women with history of Postpartum Haemorrhage (PPH) 2. Women with history of Antepartum Haemorrhage (APH) 3. Women with previous caesarean section 4. Women with 5 or more previous deliveries at over 28 weeks 5. Women who have Premature Rupture of Membranes (PROM) 6. Women with anaemia (Hb 4.0 Kgs 8. Women who have induced or augmented labour with any uterotonic drugs 9. Women with multiple pregnancies 10. Women with polyhydraminos 11. Women with pre eclampsia 12. Women with infection 13. Women who do not give a written consent

Design outcomes

Primary

MeasureTime frame
Montevideo units (MVU) (contractions over 10 minutes) for intrauterine pressure values over the first 15 minutes after placental delivery (Baby delivery)

Secondary

MeasureTime frame
1. MVU at 30, 60, 90 and 120 minutes 2. Pulse, blood pressure, and temperature at 30, 60, 90 and 120 minutes 3. Blood loss, measured in the 120 minutes after delivery

Countries

Libya

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 30, 2026